about
sameAs
Comorbidities of COPDNew selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases.Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national surveyMethacholine-Induced Variations in Airway Volume and the Slope of the Alveolar Capnogram Are Distinctly Associated with Airflow Limitation and Airway Closure.Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group.Regulation of TGF-β1-driven differentiation of human lung fibroblasts: emerging roles of cathepsin B and cystatin C.Neutrophilic Cathepsin C Is Maturated by a Multistep Proteolytic Process and Secreted by Activated Cells during Inflammatory Lung DiseasesTranscriptome of Cultured Lung Fibroblasts in Idiopathic Pulmonary Fibrosis: Meta-Analysis of Publically Available Microarray Datasets Reveals Repression of Inflammation and Immunity Pathways.Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).Pulmonary toxicity associated with the use of lenalidomide: case report of late-onset acute respiratory distress syndrome and literature review.Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines.Cysteine cathepsins and cystatins: from ancillary tasks to prominent status in lung diseases.DIPNECH: when to suggest this diagnosis on CT.Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.Pulmonary manifestations of Sjögren's syndrome.Angiogenesis stimulated by human kallikrein-related peptidase 12 acting via a platelet-derived growth factor B-dependent paracrine pathway.Asthma and Hypogammaglobulinemia: an Asthma Phenotype with Low Type 2 Inflammation.Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.Regulation of hepatocyte growth factor secretion by fibroblasts in patients with acute lung injury.What are the characteristics of asthma patients with elevated serum IgG4 levels?Keratinocyte growth factor protects against elastase-induced pulmonary emphysema in mice.Dendritic cells accumulate in human fibrotic interstitial lung disease.[Interstitial lung disease in connective tissue disorders].Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 Western patients.Tracheal involvement in ulcerative colitis: clinical presentation and potential interest of 2-deoxy-2[¹⁸F]fluoro-D-glucose positron emission tomography (¹⁸F-FDG PET) for the management.HGF synthesis in human lung fibroblasts is regulated by oncostatin M.Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer.Primary Sjögren's syndrome and occupational risk factors: A case-control study.Monoclonal Anti-TNF-α Antibodies for Severe Steroid-Dependent Asthma: A Case Series.Proteomic demonstration of the recurrent presence of inter-alpha-inhibitor H4 heavy-chain during aspergillosis induced in an animal model.Discordance in cathepsin B and cystatin C expressions in bronchoalveolar fluids between murine bleomycin-induced fibrosis and human idiopathic fibrosis.Defect of hepatocyte growth factor production by fibroblasts in human pulmonary emphysema.Keratinocyte growth factor expression by fibroblasts in pulmonary fibrosis: poor response to interleukin-1beta.Activation of somatostatin receptors attenuates pulmonary fibrosis.Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?Ground-glass computed tomography pattern in chronic beryllium disease: pathologic substratum and evolution.A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.Human cystatin C: a new biomarker of idiopathic pulmonary fibrosis?Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease.[Drug treatments for idiopathic pulmonary fibrosis].
P50
Q26853036-4BD37209-05DB-4D33-BB70-2673F0F28432Q27314812-716853B9-45BC-4F46-B302-94135F8CE81EQ28596805-887A4B3D-EA20-4000-83BB-8D041C9DB365Q30397018-D6199846-9BAC-4E9E-BC29-024AE87C8716Q30991084-791C6867-D337-4725-A7A5-90AD5F65A8C0Q33718504-715FF924-20F0-4B13-A34F-E13E28F1E94DQ36884629-773DB171-54D2-4BF5-BDE2-BCA6E66B4776Q37534819-98DDD90E-48B2-4654-9FB6-0F359E8BC85EQ38079492-D64ACCC3-7B1D-4D01-A3C4-A3FB80DC3284Q38173097-2D5639A7-0CA9-452A-AB5D-608EADC64D8DQ38216396-85649F6B-CC6E-4BA3-8A9D-E892EBCBD3BDQ38245344-05F83B27-10F1-44E0-89A6-A725A1B0569EQ38281332-757DC712-CC05-4382-A3D6-E476A4FBC5ACQ38753410-2436B6CB-F272-4637-B2E7-6C8AECF1D2D6Q38753410-5CB60AEA-B7F6-4C46-85E8-45E9D87721DDQ38849537-0E328CA9-28B0-45F2-9C70-C60B4D58B8A2Q39063497-6D99130E-B79B-44CE-9F91-DFE3D642AF4AQ39313937-3F3F91B0-FE49-4188-9DE9-15E855824A92Q39850267-E5649CB0-CA01-4273-9CA0-3E32D42241AEQ40038196-DB486DD0-2CE4-48D7-B28A-8A81737ED4CFQ40045578-C617D051-9634-45F7-9943-81754C9860ABQ40086028-74E9CB0F-86C9-49B1-9206-E519A9FEA4E2Q40180589-1CD256E3-B424-4E97-AC7A-26E0B819B67DQ40184572-4B226874-7408-4F94-8B39-019DD9DB1C52Q40217670-7AC17929-00DC-4DBC-B468-D7EDC2071FB7Q40276814-7833D524-6555-435D-A87D-B202265151C0Q40281969-3A9A4F95-EFA4-49FA-80EF-9BBF67C2BD49Q41441753-CA8A374B-CE8E-45E3-B942-562B97A282FCQ41745984-055041E8-8C53-402B-953A-C7A163249A1AQ41823738-1E77910D-7936-4795-BD39-95EA8434E141Q42235927-11FF9371-FF78-434C-BFE9-D0E4320E7F7FQ42391679-5A82F57B-F108-4983-903D-42D03880B2C0Q42471350-D6DA85FF-ECCC-456A-AD88-0B0F56022EA1Q42473562-807B8857-65EB-4531-BA73-FC0218A1F183Q42520503-5817C66E-A7E4-45AD-AD2C-95BCC88E5867Q44098491-C3728973-59D1-4E87-90C7-9F185B1BA786Q44529402-43F537FC-C862-4D10-AF6A-95CBBF707D18Q44855492-88248802-E553-4C6B-928A-609B6DD3DC93Q44870181-4BACE44E-6786-4EEA-9D4A-0E38ADAAD2A6Q45989213-26308B30-0428-4C48-9085-A8C26C607D7C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sylvain Marchand-Adam
@ast
Sylvain Marchand-Adam
@en
Sylvain Marchand-Adam
@es
Sylvain Marchand-Adam
@nl
Sylvain Marchand-Adam
@sl
type
label
Sylvain Marchand-Adam
@ast
Sylvain Marchand-Adam
@en
Sylvain Marchand-Adam
@es
Sylvain Marchand-Adam
@nl
Sylvain Marchand-Adam
@sl
prefLabel
Sylvain Marchand-Adam
@ast
Sylvain Marchand-Adam
@en
Sylvain Marchand-Adam
@es
Sylvain Marchand-Adam
@nl
Sylvain Marchand-Adam
@sl
P106
P108
P21
P31
P496
0000-0002-9522-3738